[go: up one dir, main page]

WO2011086182A3 - Comprimés à libération prolongée de pramipexole - Google Patents

Comprimés à libération prolongée de pramipexole Download PDF

Info

Publication number
WO2011086182A3
WO2011086182A3 PCT/EP2011/050542 EP2011050542W WO2011086182A3 WO 2011086182 A3 WO2011086182 A3 WO 2011086182A3 EP 2011050542 W EP2011050542 W EP 2011050542W WO 2011086182 A3 WO2011086182 A3 WO 2011086182A3
Authority
WO
WIPO (PCT)
Prior art keywords
extended release
release tablets
pramipexole extended
pramipexole
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2011/050542
Other languages
English (en)
Other versions
WO2011086182A2 (fr
Inventor
Asad Abukhalil
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthon BV
Original Assignee
Synthon BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthon BV filed Critical Synthon BV
Priority to EP11700346A priority Critical patent/EP2525786A2/fr
Publication of WO2011086182A2 publication Critical patent/WO2011086182A2/fr
Publication of WO2011086182A3 publication Critical patent/WO2011086182A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

La présente invention concerne un comprimé à libération prolongée de pramipexole qui peut être formé avec un polymère neutre gonflant dans l'eau, un polymère anionique gonflant dans l'eau, et facultativement un diluant hydrosoluble.
PCT/EP2011/050542 2010-01-18 2011-01-17 Comprimés à libération prolongée de pramipexole Ceased WO2011086182A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP11700346A EP2525786A2 (fr) 2010-01-18 2011-01-17 Comprimés à libération prolongée de pramipexole

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29601210P 2010-01-18 2010-01-18
US61/296,012 2010-01-18

Publications (2)

Publication Number Publication Date
WO2011086182A2 WO2011086182A2 (fr) 2011-07-21
WO2011086182A3 true WO2011086182A3 (fr) 2012-03-15

Family

ID=43799494

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2011/050542 Ceased WO2011086182A2 (fr) 2010-01-18 2011-01-17 Comprimés à libération prolongée de pramipexole

Country Status (2)

Country Link
EP (1) EP2525786A2 (fr)
WO (1) WO2011086182A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105796519A (zh) * 2014-12-30 2016-07-27 浙江京新药业股份有限公司 盐酸普拉克索缓释片及其制备方法
CN106474084B (zh) * 2015-08-28 2020-12-11 江苏先声药业有限公司 一种盐酸普拉克索缓释制剂及其制备方法
CN114939112B (zh) * 2017-12-28 2024-03-01 北京北大维信生物科技有限公司 普拉克索缓释药物组合物、其制备方法及用途

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050175691A1 (en) * 2002-07-25 2005-08-11 Lee Ernest J. Pramipexole once-daily dosage form
WO2006015942A1 (fr) * 2004-08-13 2006-02-16 Boehringer Ingelheim International Gmbh Préparation de comprimé à autorisation de sortie élargie, contenant du pramipexole ou un sel de pramipexole pharmaceutiquement acceptable, procédé de fabrication et d’utilisation de ce comprimé
WO2007090881A2 (fr) * 2006-02-10 2007-08-16 Boehringer Ingelheim International Gmbh Formulation a liberation modifiee

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0186087B1 (fr) 1984-12-22 1989-08-23 Dr. Karl Thomae GmbH Tétrahydro-benzothiazoles, leur procédé de préparation et leur utilisation comme intermédiaires ou médicaments
US20050226926A1 (en) 2002-07-25 2005-10-13 Pfizer Inc Sustained-release tablet composition of pramipexole

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050175691A1 (en) * 2002-07-25 2005-08-11 Lee Ernest J. Pramipexole once-daily dosage form
WO2006015942A1 (fr) * 2004-08-13 2006-02-16 Boehringer Ingelheim International Gmbh Préparation de comprimé à autorisation de sortie élargie, contenant du pramipexole ou un sel de pramipexole pharmaceutiquement acceptable, procédé de fabrication et d’utilisation de ce comprimé
WO2006015944A2 (fr) * 2004-08-13 2006-02-16 Boehringer Ingelheim International Gmbh Préparation d’un comprimé à autorisation de sortie élargie, contenant du pramipexole ou un sel de pramipexole pharmaceutiquement acceptable, procédé de fabrication et d’utilisation de ce comprimé
WO2007090881A2 (fr) * 2006-02-10 2007-08-16 Boehringer Ingelheim International Gmbh Formulation a liberation modifiee

Also Published As

Publication number Publication date
WO2011086182A2 (fr) 2011-07-21
EP2525786A2 (fr) 2012-11-28

Similar Documents

Publication Publication Date Title
WO2012134613A3 (fr) Complexes de métaux de transition pyridyldiamido pyridyldiamido, leurs production et utilisation
EP3382028B8 (fr) Événement 8264.44.06.1 empilé de tolérance aux herbicides, lignées de soja transgénique associées et détection dudit événement
BRPI0816865A2 (pt) Monitoramento de pressão anular durante fraturamento hidráulico.
WO2012006538A8 (fr) N-éthyl-n-phényl-1,2-dihydro-4-hydroxy-5-chloro-1-méthyl-2-oxoquinoléine-3-carboxamide deutéré, sels de ce composé et utilisations correspondantes
ZA201005118B (en) Aqueous polymer dispersions,method for the production and use thereof
PL2443483T3 (pl) Wielorozgałęzione makromonomery, materiały polimerowe i soczewki kontaktowe je zawierające
WO2014074760A3 (fr) Moule d'injection à mécanisme sous pression et à sécurité intégrée
EP2449043B8 (fr) Dispersions de polyuréthane-polymère acrylique et leurs utilisations
WO2011057224A3 (fr) Bioconjugués de polymère zwitterionique et procédés associés
USD699769S1 (en) Mold split insert
WO2014058967A3 (fr) Système anti-rotation pour raccordement mâle-femelle
WO2012036842A3 (fr) Configuration de capteur de pression pour réservoir sous pression
IN2014DN10578A (fr)
EP3247781A4 (fr) Polymère facilitant le lavage dans un acide solide
WO2011117271A3 (fr) Mélanges fongicides basés sur des azolopyrimidinylamines
IT1404855B1 (it) Commutatore di pressione a ripristino manuale.
WO2011017128A3 (fr) Chariot multi-usages
WO2011086182A3 (fr) Comprimés à libération prolongée de pramipexole
PL2638374T3 (pl) Zespół membrany dla czujnika ciśnienia i czujnik ciśnienia wyposażony w taki zespół
GB201106016D0 (en) Polymers
WO2012001532A3 (fr) Dispositif médical comportant une intégration cellulaire activée prédéfinie
WO2010047789A3 (fr) Gabarit de nano-impression à parois latérales à double chanfrein
GB2472676B (en) Monomers, polymers, dispersions and inks
EP2562198A4 (fr) Copolymère du fluorène, procédé pour sa préparation et son utilisation
WO2012094632A3 (fr) Procédé de réticulation et articles produits par celui-ci

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11700346

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2011700346

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: DE